Osiris Therapeutics, Inc. , the leading company focused on developing and marketing stem cell products to treat serious medical conditions, announced today the successful conclusion of a patent challenge in Australia by an opponent whose identity under Australian law was not disclosed.
http://www.businesswire.com/portal/site/topix/index.jsp?ndmViewId=news_view&newsId=20130218005754&newsLang=en&ndmConfigId=1000639&vnsId=41
http://www.businesswire.com/portal/site/topix/index.jsp?ndmViewId=news_view&newsId=20130218005754&newsLang=en&ndmConfigId=1000639&vnsId=41
No comments:
Post a Comment